close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

A

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

Strona główna・Stock List・Nektar Therapeutics
Search

Nektar Therapeutics

Open

36.86 2.56

Buy

Price update 21 sty 2026, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

35.04

Max

36.94

Key metrics

By Trading Economics

Income

6.1M

-36M

Sales

615K

12M

EPS

-1.87

Profit margin

-301.289

Employees

61

EBITDA

6.9M

-29M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+175.24% upside

Dividends

By Dow Jones

Next Earnings

11 mar 2026

Market Stats

By TradingEconomics

Market Cap

-373M

766M

Previous open

34.3

Previous close

36.86

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 sty 2026, 23:43 UTC

Market Talk

Gold Consolidates; May Face Technical Correction -- Market Talk

DJ

Read

20 sty 2026, 23:42 UTC

Market Talk

Nikkei May Fall Amid Concerns Over U.S.-Europe Trade Relations -- Market Talk

DJ

Read

20 sty 2026, 23:41 UTC

Earnings

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- 2nd Update

DJ

Read

20 sty 2026, 23:29 UTC

Market Talk

RBA Rate Hike in February Would Be a Painful One -- Market Talk

DJ

Read

20 sty 2026, 23:26 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

20 sty 2026, 23:26 UTC

Market Talk

James Hardie Appeals More as Reece's U.S. Strategy Comes Under Scrutiny -- Market Talk

DJ

Read

20 sty 2026, 22:45 UTC

Acquisitions, Mergers, Takeovers

ACCC: Ampol-EG Deal Is First Assessment Subject to Phase 2 Review Under New Merger Control Regime

DJ

Read

20 sty 2026, 22:45 UTC

Acquisitions, Mergers, Takeovers

ACCC Seeks Submissions in Response to Phase 2 Notice by February 4

DJ

Read

20 sty 2026, 22:44 UTC

Acquisitions, Mergers, Takeovers

ACCC: Ampol's Offer to Sell 19 Retail Fuel Sites Doesn't Adequately Address Issues

DJ

Read

20 sty 2026, 22:44 UTC

Acquisitions, Mergers, Takeovers

ACCC Identifies 115 EG Sites Where Deal Could Substantially Lessen Competition

DJ

Read

20 sty 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

ACCC Says Deal Could Substantially Lessen Competition in Retail Supply of Petrol, Diesel in Several Markets in Australia

DJ

Read

20 sty 2026, 22:43 UTC

Acquisitions, Mergers, Takeovers

Ampol's Acquisition of EG Australia to Undergo In-Depth Review by Competition Regulator

DJ

Read

20 sty 2026, 22:27 UTC

Acquisitions, Mergers, Takeovers

Netflix Plans to Roll Out New Mobile User Interface Later This Year, Co-CEO Says

DJ

Read

20 sty 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

Netflix Co-CEO Sees Uptick in Engagement for TV-Based Games

DJ

Read

20 sty 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Netflix Would Keep 45-Day Theater Release Window for Warner Bros. Films, Co-CEO Says

DJ

Read

20 sty 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Netflix Excited to Strengthen Warner Bros.'s Theatrical-Distribution Business, Co-CEO Says

DJ

Read

20 sty 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Netflix Pleased With Early Results for Podcasts, Co-CEO Says

DJ

Read

20 sty 2026, 22:18 UTC

Earnings

Netflix Stock Is Falling. This Is Overshadowing the Streamer's Earnings Beat. -- Barrons.com

DJ

Read

20 sty 2026, 22:17 UTC

Acquisitions, Mergers, Takeovers

Netflix's Live Events Are Boosting Retention, Co-CEO Says

DJ

Read

20 sty 2026, 22:16 UTC

Acquisitions, Mergers, Takeovers

Netflix Remains 'Very Excited' About Live-Events Offering, Co-CEO Says

DJ

Read

20 sty 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Netflix's Proposed Deal for Warner Bros. Would Protect, Create Jobs, Co-CEO Says

DJ

Read

20 sty 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Netflix Competes for Attention Across Streaming, Broadcast, Cable, Gaming, Social Media, Video Platforms, Co-CEO Says

DJ

Read

20 sty 2026, 22:13 UTC

Acquisitions, Mergers, Takeovers

Netflix Co-CEO: TV Landscape Has Never Been More Competitive

DJ

Read

20 sty 2026, 22:11 UTC

Acquisitions, Mergers, Takeovers

Netflix Confident Warner Bros. Deal Would Pass Regulatory Review, Co-CEO Says

DJ

Read

20 sty 2026, 22:10 UTC

Acquisitions, Mergers, Takeovers

Netflix Would Leverage Global Footprint, Streaming Expertise to Improve Warner Bros.'s HBO Max Service, Co-CEO Says

DJ

Read

20 sty 2026, 22:08 UTC

Acquisitions, Mergers, Takeovers

Netflix Won't Raise Prices During Regulatory-Review Process for Pending Warner Bros. Deal, Co-CEO Says

DJ

Read

20 sty 2026, 22:07 UTC

Acquisitions, Mergers, Takeovers

Netflix Sees Warner Bros. as Another Mechanism to Improve Offerings, Co-CEO Says

DJ

Read

20 sty 2026, 22:06 UTC

Earnings

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- Update

DJ

Read

20 sty 2026, 22:00 UTC

Market Talk
Acquisitions, Mergers, Takeovers

ESG Roundup: Market Talk

DJ

Read

20 sty 2026, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

175.24% upside

12 Months Forecast

Average 103.71 USD  175.24%

High 135 USD

Low 30 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

6

Buy

1

Hold

1

Sell

Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

100.48

↑ +1.87%

A

Agilent Technologies Inc

139.65

↑ +3%

VEEV

Veeva Systems Inc

219.8

↑ +1.79%

HQY

HealthEquity Inc

84.32

↑ +0.78%

NEOG

Neogen Corp

9.86

↑ +5.45%
help-icon Live chat